[
  {
    "ts": null,
    "headline": "Moderna Cuts Costs as COVID Sales Slump",
    "summary": "Trims 2026 operating expenses by up to $500M after Q1 revenue plunges 35% to $108M",
    "url": "https://finnhub.io/api/news?id=de90c2c68b34b3a68d3dad3a3ffbcd83a62c02660d67bb1090dc54a89cea97cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746127080,
      "headline": "Moderna Cuts Costs as COVID Sales Slump",
      "id": 134185690,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Trims 2026 operating expenses by up to $500M after Q1 revenue plunges 35% to $108M",
      "url": "https://finnhub.io/api/news?id=de90c2c68b34b3a68d3dad3a3ffbcd83a62c02660d67bb1090dc54a89cea97cf"
    }
  },
  {
    "ts": null,
    "headline": "Moderna combination flu, COVID shot delayed amid FDA scrutiny",
    "summary": "Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.",
    "url": "https://finnhub.io/api/news?id=639f27917063a26792364718322f240ac0e02ea35d6e40875d2b68e36b421ac3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746117480,
      "headline": "Moderna combination flu, COVID shot delayed amid FDA scrutiny",
      "id": 134185691,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.",
      "url": "https://finnhub.io/api/news?id=639f27917063a26792364718322f240ac0e02ea35d6e40875d2b68e36b421ac3"
    }
  },
  {
    "ts": null,
    "headline": "Moderna First-Quarter Loss Unexpectedly Improves Even as Revenue Drops",
    "summary": "Moderna's (MRNA) first-quarter loss unexpectedly improved year on year as a drop in expenses helped",
    "url": "https://finnhub.io/api/news?id=647cf38a46880932849b5414fc223803a0e208f1021adf1afa3d2cd73b9e70b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746116155,
      "headline": "Moderna First-Quarter Loss Unexpectedly Improves Even as Revenue Drops",
      "id": 134174318,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna's (MRNA) first-quarter loss unexpectedly improved year on year as a drop in expenses helped",
      "url": "https://finnhub.io/api/news?id=647cf38a46880932849b5414fc223803a0e208f1021adf1afa3d2cd73b9e70b1"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Shares Drop As Political Picture Worsens",
    "summary": "Moderna  laid out plans Thursday to slash future costs in an effort to stop bleeding cash, but a worsening political environment for vaccine companies is making its plan a tough sell.  Moderna stuck by its prior guidance and reported a quarterly loss of $2.52 a share; the consensus estimate was a per-share loss of $3.12.  Revenue was $108 million, in line with the $106 million consensus estimate.",
    "url": "https://finnhub.io/api/news?id=69e7b201745901d792a4e596be704bf845104e504351428ce60a916121b2f733",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746113160,
      "headline": "Moderna Shares Drop As Political Picture Worsens",
      "id": 134174319,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna  laid out plans Thursday to slash future costs in an effort to stop bleeding cash, but a worsening political environment for vaccine companies is making its plan a tough sell.  Moderna stuck by its prior guidance and reported a quarterly loss of $2.52 a share; the consensus estimate was a per-share loss of $3.12.  Revenue was $108 million, in line with the $106 million consensus estimate.",
      "url": "https://finnhub.io/api/news?id=69e7b201745901d792a4e596be704bf845104e504351428ce60a916121b2f733"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost Cuts",
    "summary": "MRNA reports mixed Q1 results. The company reiterates 2025 sales guidance but announces a cost-cutting initiative to reduce expenses significantly by 2027.",
    "url": "https://finnhub.io/api/news?id=d333c2a13da859e98052b22596953d434ca56d33ec734d1a813bfbfb8b69dcfc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746112920,
      "headline": "Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost Cuts",
      "id": 134174320,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "MRNA reports mixed Q1 results. The company reiterates 2025 sales guidance but announces a cost-cutting initiative to reduce expenses significantly by 2027.",
      "url": "https://finnhub.io/api/news?id=d333c2a13da859e98052b22596953d434ca56d33ec734d1a813bfbfb8b69dcfc"
    }
  },
  {
    "ts": null,
    "headline": "Wayfair beats, Estee Lauder outlook, Moderna: Trending Tickers",
    "summary": "Wayfair (W) stock gains after reporting a surprise earnings beat, with the company saying its business model should minimize tariff impacts. Estee Lauder (EL) warns of a slowdown in sales in 2025 but expects a return to growth in 2026, assuming there is more clarity on Trump's tariff policies. Moderna (MRNA) announces plans to cut $1.5 billion after reporting a 35% drop in revenue from the year-ago period. To watch more expert insights and analysis on the latest market action, check out more Wealth here.",
    "url": "https://finnhub.io/api/news?id=d605a8368cec604a509127855348b8bd8632862212136ef0d6f21d79bc17b309",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746112845,
      "headline": "Wayfair beats, Estee Lauder outlook, Moderna: Trending Tickers",
      "id": 134174240,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Wayfair (W) stock gains after reporting a surprise earnings beat, with the company saying its business model should minimize tariff impacts. Estee Lauder (EL) warns of a slowdown in sales in 2025 but expects a return to growth in 2026, assuming there is more clarity on Trump's tariff policies. Moderna (MRNA) announces plans to cut $1.5 billion after reporting a 35% drop in revenue from the year-ago period. To watch more expert insights and analysis on the latest market action, check out more Wealth here.",
      "url": "https://finnhub.io/api/news?id=d605a8368cec604a509127855348b8bd8632862212136ef0d6f21d79bc17b309"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: Regulatory Hurdles And Market Challenges Prompt Downgrade To Sell",
    "summary": "Moderna faces revenue declines, regulatory setbacks, and market challenges as COVID-19 vaccine demand wanes. Learn more about MRNA stock here.",
    "url": "https://finnhub.io/api/news?id=b99a4fcdda3ba0527d2c2b2dd8c0a4a41c4a47a2d3f4b04d58f47a2e46cb3458",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746106212,
      "headline": "Moderna: Regulatory Hurdles And Market Challenges Prompt Downgrade To Sell",
      "id": 134175280,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1253985645/image_1253985645.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Moderna faces revenue declines, regulatory setbacks, and market challenges as COVID-19 vaccine demand wanes. Learn more about MRNA stock here.",
      "url": "https://finnhub.io/api/news?id=b99a4fcdda3ba0527d2c2b2dd8c0a4a41c4a47a2d3f4b04d58f47a2e46cb3458"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Crumbles As Vaccine Troubles Rattle Its Topline",
    "summary": "Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.",
    "url": "https://finnhub.io/api/news?id=f4ba9b8512cd1f7e1b09d8a5b100d6c44c596b45d5041030c718bfabd1884cc5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746105059,
      "headline": "Moderna Stock Crumbles As Vaccine Troubles Rattle Its Topline",
      "id": 134174322,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products, Spikevax and mResvia.",
      "url": "https://finnhub.io/api/news?id=f4ba9b8512cd1f7e1b09d8a5b100d6c44c596b45d5041030c718bfabd1884cc5"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Q1 2025 Earnings Call Transcript",
    "summary": "Moderna, Inc. (NASDAQ:MRNA) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsLavina Talukdar - Senior Vice President, Investor...",
    "url": "https://finnhub.io/api/news?id=78dfd1bd82a4ae48191d53d149f6c379af7b8e485a293023be1ce433c62fe1d2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746100901,
      "headline": "Moderna, Inc. (MRNA) Q1 2025 Earnings Call Transcript",
      "id": 134172947,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Moderna, Inc. (NASDAQ:MRNA) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsLavina Talukdar - Senior Vice President, Investor...",
      "url": "https://finnhub.io/api/news?id=78dfd1bd82a4ae48191d53d149f6c379af7b8e485a293023be1ce433c62fe1d2"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (MRNA) Reports Q1 Loss, Lags Revenue Estimates",
    "summary": "Moderna (MRNA) delivered earnings and revenue surprises of 13.70% and 14.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=2139eb937f4352c956ab7c717b74ad63899f6c7d0af413523495dea36d66faf9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746099605,
      "headline": "Moderna (MRNA) Reports Q1 Loss, Lags Revenue Estimates",
      "id": 134174323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) delivered earnings and revenue surprises of 13.70% and 14.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=2139eb937f4352c956ab7c717b74ad63899f6c7d0af413523495dea36d66faf9"
    }
  },
  {
    "ts": null,
    "headline": "Moderna says FDA has been constructive, but delays flu/COVID shot",
    "summary": "Moderna on Thursday pushedback the time frame for likely approval of a combination vaccinemeant to protect against both COVID-19 and influenza, but saidexchanges with U.S. drug regulators have...",
    "url": "https://finnhub.io/api/news?id=21b0767f8069fe376e08e63ee5c34635c8007516ced0c16df7a09660d7e47397",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746097487,
      "headline": "Moderna says FDA has been constructive, but delays flu/COVID shot",
      "id": 134172516,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna on Thursday pushedback the time frame for likely approval of a combination vaccinemeant to protect against both COVID-19 and influenza, but saidexchanges with U.S. drug regulators have...",
      "url": "https://finnhub.io/api/news?id=21b0767f8069fe376e08e63ee5c34635c8007516ced0c16df7a09660d7e47397"
    }
  },
  {
    "ts": null,
    "headline": "Moderna (NASDAQ:MRNA) Misses Q1 Revenue Estimates",
    "summary": "Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The company’s full-year revenue guidance of $2 billion at the midpoint came in 6.1% below analysts’ estimates. Its GAAP loss of $2.52 per share was 18.6% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=f12589b87a256cc41544126a70e55a169b1a47d0b004f648799fe480e8dc984e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746096524,
      "headline": "Moderna (NASDAQ:MRNA) Misses Q1 Revenue Estimates",
      "id": 134174324,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The company’s full-year revenue guidance of $2 billion at the midpoint came in 6.1% below analysts’ estimates. Its GAAP loss of $2.52 per share was 18.6% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=f12589b87a256cc41544126a70e55a169b1a47d0b004f648799fe480e8dc984e"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Posts Loss, Citing Seasonality of Respiratory Business",
    "summary": "Moderna logged a first-quarter loss as revenue fell, dragged down by lower product sales, though the company said it expects demand to increase during cold and flu season later this year.",
    "url": "https://finnhub.io/api/news?id=4a1c6e5a085a2717bddacf71bd33adc07f2c6ffb66fcb38cfe9dd118fbc8f0e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746095880,
      "headline": "Moderna Posts Loss, Citing Seasonality of Respiratory Business",
      "id": 134174325,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna logged a first-quarter loss as revenue fell, dragged down by lower product sales, though the company said it expects demand to increase during cold and flu season later this year.",
      "url": "https://finnhub.io/api/news?id=4a1c6e5a085a2717bddacf71bd33adc07f2c6ffb66fcb38cfe9dd118fbc8f0e7"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: Q1 Earnings Snapshot",
    "summary": "MRNA) on Thursday reported a loss of $971 million in its first quarter. The Cambridge, Massachusetts-based company said it had a loss of $2.52 per share. The results topped Wall Street expectations.",
    "url": "https://finnhub.io/api/news?id=7d627e8d42d260524509c61d8f7646cc49904001a786f7876960f813ca924ce9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746095847,
      "headline": "Moderna: Q1 Earnings Snapshot",
      "id": 134174326,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "MRNA) on Thursday reported a loss of $971 million in its first quarter. The Cambridge, Massachusetts-based company said it had a loss of $2.52 per share. The results topped Wall Street expectations.",
      "url": "https://finnhub.io/api/news?id=7d627e8d42d260524509c61d8f7646cc49904001a786f7876960f813ca924ce9"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates",
    "summary": "Reports first quarter revenues of $0.1 billion, GAAP net loss of $(1.0) billion and GAAP EPS of $(2.52) Reiterates 2025 expected revenue range of $1.5 to $2.5 billion and 2025 year-end cash balance of approximately $6 billion Announces reduction of ...",
    "url": "https://finnhub.io/api/news?id=ec0892693a20b43945b4a0ec967170d3da3d2c20d13cc00a8f16cb19e3b8a19a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746095400,
      "headline": "Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates",
      "id": 134174328,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Reports first quarter revenues of $0.1 billion, GAAP net loss of $(1.0) billion and GAAP EPS of $(2.52) Reiterates 2025 expected revenue range of $1.5 to $2.5 billion and 2025 year-end cash balance of approximately $6 billion Announces reduction of ...",
      "url": "https://finnhub.io/api/news?id=ec0892693a20b43945b4a0ec967170d3da3d2c20d13cc00a8f16cb19e3b8a19a"
    }
  },
  {
    "ts": null,
    "headline": "IR Insights: Recapping Our First Quarter 2025 Earnings Report",
    "summary": "Forward-Looking Statements This post and accompanying video contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as...",
    "url": "https://finnhub.io/api/news?id=c528f552e4efc5044f2cf5617cd4beb26ffb26fea2e08aa517f76dd73822bcf3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746092775,
      "headline": "IR Insights: Recapping Our First Quarter 2025 Earnings Report",
      "id": 134171982,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Forward-Looking Statements This post and accompanying video contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as...",
      "url": "https://finnhub.io/api/news?id=c528f552e4efc5044f2cf5617cd4beb26ffb26fea2e08aa517f76dd73822bcf3"
    }
  },
  {
    "ts": null,
    "headline": "IR Insights: Recapping our First Quarter of 2025 Earnings Report",
    "summary": "Moderna has added a new blog to its website Earlier today, Moderna reported financial results and provided business updates for the first quarter of 2025. Stéphane...",
    "url": "https://finnhub.io/api/news?id=99c713fd2ac1ca1dcfd080506523fbcadbb6567046ca546c753d6a0aa22cfc36",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746092775,
      "headline": "IR Insights: Recapping our First Quarter of 2025 Earnings Report",
      "id": 134171981,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna has added a new blog to its website Earlier today, Moderna reported financial results and provided business updates for the first quarter of 2025. Stéphane...",
      "url": "https://finnhub.io/api/news?id=99c713fd2ac1ca1dcfd080506523fbcadbb6567046ca546c753d6a0aa22cfc36"
    }
  },
  {
    "ts": null,
    "headline": "Moderna beats Wall Street estimates for first-quarter profit and sales",
    "summary": "Moderna on Thursday reportedfirst-quarter profit and sales that beat Wall Street estimates,helped by the company's cost-cutting efforts following waningpost-pandemic demand for its COVID-19...",
    "url": "https://finnhub.io/api/news?id=11bd3d144667ef39505c7b1e944e8620ade4abc56f0cfd94b28a2894365de788",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746086208,
      "headline": "Moderna beats Wall Street estimates for first-quarter profit and sales",
      "id": 134171002,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna on Thursday reportedfirst-quarter profit and sales that beat Wall Street estimates,helped by the company's cost-cutting efforts following waningpost-pandemic demand for its COVID-19...",
      "url": "https://finnhub.io/api/news?id=11bd3d144667ef39505c7b1e944e8620ade4abc56f0cfd94b28a2894365de788"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. 2025 Q1 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Moderna, Inc.",
    "url": "https://finnhub.io/api/news?id=d8f49271773dbc5f1b963e37b19541060469c27a92e429e44e2f15dbf61866e7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746086163,
      "headline": "Moderna, Inc. 2025 Q1 - Results - Earnings Call Presentation",
      "id": 134171120,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Moderna, Inc.",
      "url": "https://finnhub.io/api/news?id=d8f49271773dbc5f1b963e37b19541060469c27a92e429e44e2f15dbf61866e7"
    }
  },
  {
    "ts": null,
    "headline": "Corporate Presentation (05/01/2025 00: 00",
    "summary": "First Quarter 2025 Financial Results May 1, 2025 ...",
    "url": "https://finnhub.io/api/news?id=39bb18ea64fde09de955700448063e9d11514501efc5a0a48b609edf6874cd40",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746083765,
      "headline": "Corporate Presentation (05/01/2025 00: 00",
      "id": 134170721,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "First Quarter 2025 Financial Results May 1, 2025 ...",
      "url": "https://finnhub.io/api/news?id=39bb18ea64fde09de955700448063e9d11514501efc5a0a48b609edf6874cd40"
    }
  }
]